Tokyo Tape
Sign in
← Oncolys BioPharma

Quarterly report · Q3

4588.TEDINET S100PGU8
Period2022-01-01 → 2022-09-30
Filed2022-11-04
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥785m2022-01-01 → 2022-09-30StandaloneNet sales
Revenue¥642m2021-01-01 → 2021-12-31StandaloneNet sales (5-year summary)
Revenue¥318m2021-01-01 → 2021-09-30StandaloneNet sales
Operating income−¥937m2022-01-01 → 2022-09-30StandaloneOperating income
Operating income−¥964m2021-01-01 → 2021-09-30StandaloneOperating income
Ordinary income−¥854m2022-01-01 → 2022-09-30StandaloneOrdinary income
Ordinary income−¥1.5bn2021-01-01 → 2021-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥977m2021-01-01 → 2021-09-30StandaloneOrdinary income
Profit before tax−¥833m2022-01-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax−¥977m2021-01-01 → 2021-09-30StandaloneIncome before income taxes
Net income−¥835m2022-01-01 → 2022-09-30StandaloneProfit loss
Net income−¥1.6bn2021-01-01 → 2021-12-31StandaloneNet income loss (5-year summary)
Net income−¥980m2021-01-01 → 2021-09-30StandaloneProfit loss
Total assets¥3.5bnat 2022-09-30StandaloneAssets
Total assets¥4.3bnat 2021-12-31StandaloneAssets
Total assets¥4.9bnat 2021-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥983mat 2022-09-30StandaloneLiabilities
Total liabilities¥698mat 2021-12-31StandaloneLiabilities
Net assets / equity¥2.5bnat 2022-09-30StandaloneNet assets
Net assets / equity¥3.6bnat 2021-12-31StandaloneNet assets
Net assets / equity¥4.2bnat 2021-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥2.4bnat 2022-09-30StandaloneCash and deposits
Cash and deposits¥3.5bnat 2021-12-31StandaloneCash and deposits
EPS (basic)¥-48.22022-01-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-15.432022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-95.52021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-58.422021-01-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-192021-07-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio71.3%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio83.6%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio84.9%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued17,405,200at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued17,341,100at 2021-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 303
ItemContextValueUnit
Capital stockCurrentQuarterInstant_NonConsolidatedMember3000000000JPY
Legal capital surplusPrior1YearInstant_NonConsolidatedMember9031904000JPY
Legal capital surplusCurrentQuarterInstant_NonConsolidatedMember586425000JPY
Other capital surplusPrior1YearInstant_NonConsolidatedMember31740000JPY
Other capital surplusCurrentQuarterInstant_NonConsolidatedMember－JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember9063645000JPY
Capital surplusCurrentQuarterInstant_NonConsolidatedMember586425000JPY
Retained earnings brought forwardPrior1YearInstant_NonConsolidatedMember-14516735000JPY
Retained earnings brought forwardCurrentQuarterInstant_NonConsolidatedMember-1121004000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-14516735000JPY
Retained earningsCurrentQuarterInstant_NonConsolidatedMember-1121004000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-113000JPY
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-142000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember3586312000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember2465278000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember7680000JPY
Subscription rights to sharesCurrentQuarterInstant_NonConsolidatedMember7680000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember3593992000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember2472958000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember4291876000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember3455544000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember318317000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember784509000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember148936000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember474357000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember169380000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember310152000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember1133029000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember1247533000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-963649000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-937381000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember382000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember458000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember28541000JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember100147000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember779000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember40000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember29703000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember100646000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember3191000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember3013000JPY
Amortization of restricted stock remuneration noePrior1YTDDuration_NonConsolidatedMember28116000JPY
Amortization of restricted stock remuneration noeCurrentYTDDuration_NonConsolidatedMember14676000JPY
Share acquisition rights issuance costs noePrior1YTDDuration_NonConsolidatedMember413000JPY
Share acquisition rights issuance costs noeCurrentYTDDuration_NonConsolidatedMember－JPY
Stock issuance cost noePrior1YTDDuration_NonConsolidatedMember11007000JPY
Stock issuance cost noeCurrentYTDDuration_NonConsolidatedMember30000JPY
Other noePrior1YTDDuration_NonConsolidatedMember217000JPY
Other noeCurrentYTDDuration_NonConsolidatedMember0JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember42945000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2021-12-31pass
balance sheet identitynon_consolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-09-30pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass